Coronavirus outbreak

[Me_]

23 minutes ago, kingofsurrey said:

You need to keep reading up...

 

An internal document prepared by the Vancouver School Board, using the guidance of health officials, says that those staff in schools will not be required to wear such gear.

Warren Williams, the president of CUPE 15 which represents school support workers, said members would like to wear masks, but understand there is a shortage of equipment.

 

“That would be our preference but the government is telling us it’s not necessary,” Williams said. “The Vancouver School Board is providing gloves, sanitizer and cleaning products

 

https://globalnews.ca/news/6873595/coronavirus-kids-school/

They’re doing the same thing in Quebec. Passing pamphlets to staff, students and parents saying not to worry because Covid only lives on surfaces for two hours.

 

WTH???

 

A shortage of equipment means there’s a demand. There’s even a target date: September re-entry.

 

So who is making some PPE?

 

If we can design the 777 in AutoCAD and make it fly virtually before any wing takes off, we surely can take a few months to redesign our environment without jeopardizing an entire generation that were recently born with brand new immune systems but which can be damaged fast.

 

We are lining up our young souls to fall into the mouth of Chernobyl.

 

Edited May 19, 2020 by Me_

[EdgarM]

2 minutes ago, kingofsurrey said:

You need to keep reading up...

 

An internal document prepared by the Vancouver School Board, using the guidance of health officials, says that those staff in schools will not be required to wear such gear.

Warren Williams, the president of CUPE 15 which represents school support workers, said members would like to wear masks, but understand there is a shortage of equipment.

 

“That would be our preference but the government is telling us it’s not necessary,” Williams said. “The Vancouver School Board is providing gloves, sanitizer and cleaning products

 

https://globalnews.ca/news/6873595/coronavirus-kids-school/

The employer can claim what is "needed" all they want they still must abide by the law. If they refuse, there are avenues to challenge them and believe me, they don't want to lose because they are fined big time. Like I mentioned before, the Union must stand up to them and use the law and policies to their favor. 

[kingofsurrey]

1 minute ago, EdgarM said:

The employer can claim what is "needed" all they want they still must abide by the law. If they refuse, there are avenues to challenge them and believe me, they don't want to lose because they are fined big time. Like I mentioned before, the Union must stand up to them and use the law and policies to their favor. 

BC teachers union is weaker than  a wet paper bag.  School districts will do as they want.   Teachers will be given zero PPE.  

 

Edited May 19, 2020 by kingofsurrey

[Me_]

17 minutes ago, EdgarM said:

The employer can claim what is "needed" all they want they still must abide by the law. If they refuse, there are avenues to challenge them and believe me, they don't want to lose because they are fined big time. Like I mentioned before, the Union must stand up to them and use the law and policies to their favor. 

Which will take months to solve and the teacher will probably be sent home or stop showing up...

 

...either way.

 

“Testing” half-assed guidelines and mechanisms in the school system for a mere few days is like putting your foot in straigh acid.

 

It said it on the label.

 

Edited May 19, 2020 by Me_

[JoeyJoeJoeJr. Shabadoo]

29 minutes ago, Timbermen said:

I don't know, kind of hard to argue with this lady. Look at her credentials.......thoughts?

 

I couldn't read the ridiculous scroll at the beginning so I googled her. Hard pass. I prefer my scientists to be much less partisan if at all. 

 

It's 36 minutes too, how about the coles notes? 

 

By the way, what corners of the dark web did you have to wander into to find this anyway, lol?

[EdgarM]

6 minutes ago, kingofsurrey said:

BC teachers union is weaker than  a wet paper bag.  School districts will do as they want.   Teachers will be given zero PPE.  

 

 

3 minutes ago, Me_ said:

Which will take months to solve and the teacher will probably be sent home or now show up...

 

...either way.

 

“Testing” the school system for a mere few days is like putting your foot in straigh acid.

 

It said it on the label.

 

When a perceived "Danger" exists in the workplace, refusal to work by the employees is instantaneous and the investigation starts immediately. They do not return until a decision has been made and there are no retributions to the employee afterwards. It sounds like there are useless people in the Union though and in that case, my condolences to your profession.

[Me_]

30 minutes ago, EdgarM said:

 

When a perceived "Danger" exists in the workplace, refusal to work by the employees is instantaneous and the investigation starts immediately. They do not return until a decision has been made and there are no retributions to the employee afterwards. It sounds like there are useless people in the Union though and in that case, my condolences to your profession.

Well in theory.
 

My Union is pretty good with its members. All of the other Unions I deal with are also quite on top of its employee safety and benefits, including mental, physical and sexual harassment. But I can only talk about about film Unions.

 

However, we’re a gig-based industry.
So when it all shut down, BOOM.

 

gone.

 

And not one Union in the film industry is equipped, nor designed to “secure employment” to its members.

 

Filmmaking is more like fishing; it’s high paying when you work, but it’s seasonal work so you make much less over period of time than in many other industries.This is truly an industry where your passion comes before mental health, but your mental health depends on you practicing your passion.

 

A study was made in our Union on mental health; 98% responded that they had some type of mental issue. 
 

I would argue that you have to be insane to be in this industry in the first place. I digress.

 

It is true that some Unions don’t necessarily enforce their rules nor fulfill their mandate.

 

Edited May 19, 2020 by Me_

[spur1]

2 hours ago, The 5th Line said:

No I got it the first time, just need clarification.  So school opens in September, kids back to school, parents back to work.  Kid goes down sick, time to shutdown the school, those kids need someone watching them, parents have to quit job?  

Just one parent...the other needs to stay at home and grow a garden etc. 

[spur1]

1 hour ago, Me_ said:

Funny how that works.

 

Its almost like cutting the Amazon here, burning fossil fuel there, doesn’t affect that other place...

 

No?

 

Make plastic here, use it there, trash it and it ends up in fish across the world.

No?

 

Turning hydro electrical turbines, releases mercury which all end up in the Arctic due to wind patterns.

 

Its almost as if.... we’re all part of this... thing...

 

Almost as if there is a non permanence and an interconnection between all things...

 

Probably another subject for another time.

The force is strong. 

[Me_]

19 minutes ago, spur1 said:

The force is strong. 

We really have to get our act together on this little micro droplet floating in space. 
 

We need to get her back to 0 degrees and realign our Global computer; temples, with the Galactic Soup once again. 
 

It’s been 14,000 years already.

 

They probably miss us by now.

 

But that haircut and those Air Jordan though.

 

[Timbermen]

58 minutes ago, JoeyJoeJoeJr. Shabadoo said:

I couldn't read the ridiculous scroll at the beginning so I googled her. Hard pass. I prefer my scientists to be much less partisan if at all. 

 

It's 36 minutes too, how about the coles notes? 

 

By the way, what corners of the dark web did you have to wander into to find this anyway, lol?

Facebook, I don't know if she's partisan or just wants to hold people accountable for the deaths they will cause with their policies. I just saw this myself but she's calling out any one that wants to argue with her on National Television, yet you'lll see zero mention of her on CNN. She has more credentials than all the so called journalists that will be attacking her put together.

Prof. Dolores J. Cahill, Professor of Translational Science at UCD School of Medicine, University College Dublin

Prof. Dr Dolores Cahill has over 25 years expertise in high-throughput protein array, antibody array, proteomics technology development,automation and their biomedical applications, including in biomarker discovery, diagnostics and personalised medicine. She is Professor of Translational Science, School of Medicine and at the Conway Institute at the University College Dublin (UCD) (2005-present). With her research group & collaborators, she has achieved key breakthroughs in developing and demonstrating applications of high throughput array technology in biological, diagnostics & medical research. Prof. Cahill pioneered this research at the Max-Planck-Institute of Molecular Genetics in Berlin, Germany (1996-2003) and holds several granted international patents in this vital field. Some of her activities include:

In 1996, she co-founded Protagen AG (https://protagen.com/) in Dortmund, including with Prof. Helmut Meyer, as a spin-out of the Max-Planck-Institute to commercialise her discoveries. Protagen Protein Services (https://protagenproteinservices.com/) a 2014 spin-off company of Protagen delivers expert protein, antibody, proteomics & peptide contract services to the pharmaceutical industry & health care sectors. Both companies have advanced these technologies & applications; Protagen has screened and profiled the autoantibody repertoire of over 20,000 patients (https://protagen.com/data-and-insight...). Protagen AG and Protagen Protein Services have over 200 employees in 2018. Since 2016, Prof. Cahill is a shareholder & Advisory Board member of Atturos Ltd, Prof. Stephen Pennington’s UCD spin-out company nvolved in improved Prostate Cancer diagnosis (http://atturos.com/ and http://atturos.com/company/advisors/).

She received her Honours degree in Molecular Genetics from Trinity College Dublin (1989) and her PhD in Immunology from Dublin City University (1994). While studying in Trinity, she was awarded the Irish American Fellowship Prize (1988) to research at Prof. Pringle’s laboratory in the University of Michigan, Ann Arbor, USA. During her undergraduate & PhD studies, she worked, including as Assistant Manager, in fine-dining Country Clubs in Long Island, New York (4 summers) & in Tenafly, New Jersey (4 summers). On obtaining her PhD, she obtained an EU ‘Human Capital & Mobility’ Post-doctoral Fellowship at the Technical University, Munich, Germany (1994-1995). Prof. Cahill became Group Leader of the Protein Technology Group in the Max-Planck-Institute of Molecular Genetics, Berlin (1996-2003). She obtained an Associate Professor position, in the Department of Clinical Pharmacology and Director of Proteomics Core, RCSI, Dublin (2000-2005). Since 2005 – present, she is Full Professor of Translational Science in the School of Medicine, University College Dublin and she has extensive management experience, including successfully obtaining funding from the European Commission (FP4, FP5, FP6, FP7 and Horizon 2020), Science Foundation Ireland, Enterprise Ireland, Health Research Board & successfully writing, project managing, publishing & reporting on all financial & regulatory aspects in academic & private sectors, in the companies she co-founded.

 She has over 100 peer reviewed publications, with over 5000 citations and a H-index is 31, which is in the top 10% globally for the Biomedicine discipline. Prof. Cahill is internationally recognised for her biomedical research, publications and patent record in life sciences, biotechnology, personalised healthcare, personalised medicine, diagnostics, biomarker discovery and validation, proteomics, biotechnology, high content protein and antibody arrays and their biomedical, diagnostic and clinical applications. Her publications have demonstrated utility and applications in the research, commercial & clinical sectors and include characterisation of antibodies specificity (including therapeutic antibodies), biomarker discovery, diagnostics, assay development, protein-interaction studies, proteomics, large scale/systems biology research, validating biomarker panels in diagnostic clinical trial, personalised medicine and assessing immune related adverse events. She has given over 100 Keynotes Lectures in Ireland, UK, Europe, USA, China, Japan, South Korea, Australia, South America. For example, she is invited to the ‘5th Precision Medicine and Biomarkers Leaders’ Summit’ in Munich in September 2018 & will Chair a Roundtable on Personalised Medicine and Adverse Events to discuss whether lessons can be learned from cancer immunotherapy and immune related adverse events to provide insight into understanding adverse events and personalised medicine and finding adverse event predictive biomarkers

Edited May 19, 2020 by Timbermen

[Me_]

4 minutes ago, Timbermen said:

Facebook, I don't know if she's partisan or just wants to hold people accountable for the deaths they will cause with their policies. I just saw this myself but she's calling out any one that wants to argue with her on National Television, yet you'lll see zero mention of her on CNN. She has more credentials than all the so called journalists that will be attacking her put together.

Prof. Dolores J. Cahill, Professor of Translational Science at UCD School of Medicine, University College Dublin Prof. Dr Dolores Cahill has over 25 years expertise in high-throughput protein array, antibody array, proteomics technology development,automation and their biomedical applications, including in biomarker discovery, diagnostics and personalised medicine. She is Professor of Translational Science, School of Medicine and at the Conway Institute at the University College Dublin (UCD) (2005-present). With her research group & collaborators, she has achieved key breakthroughs in developing and demonstrating applications of high throughput array technology in biological, diagnostics & medical research. Prof. Cahill pioneered this research at the Max-Planck-Institute of Molecular Genetics in Berlin, Germany (1996-2003) and holds several granted international patents in this vital field. Some of her activities include: In 1996, she co-founded Protagen AG (https://protagen.com/) in Dortmund, including with Prof. Helmut Meyer, as a spin-out of the Max-Planck-Institute to commercialise her discoveries. Protagen Protein Services (https://protagenproteinservices.com/) a 2014 spin-off company of Protagen delivers expert protein, antibody, proteomics & peptide contract services to the pharmaceutical industry & health care sectors. Both companies have advanced these technologies & applications; Protagen has screened and profiled the autoantibody repertoire of over 20,000 patients (https://protagen.com/data-and-insight...). Protagen AG and Protagen Protein Services have over 200 employees in 2018. Since 2016, Prof. Cahill is a shareholder & Advisory Board member of Atturos Ltd, Prof. Stephen Pennington’s UCD spin-out company nvolved in improved Prostate Cancer diagnosis (http://atturos.com/ and http://atturos.com/company/advisors/). She received her Honours degree in Molecular Genetics from Trinity College Dublin (1989) and her PhD in Immunology from Dublin City University (1994). While studying in Trinity, she was awarded the Irish American Fellowship Prize (1988) to research at Prof. Pringle’s laboratory in the University of Michigan, Ann Arbor, USA. During her undergraduate & PhD studies, she worked, including as Assistant Manager, in fine-dining Country Clubs in Long Island, New York (4 summers) & in Tenafly, New Jersey (4 summers). On obtaining her PhD, she obtained an EU ‘Human Capital & Mobility’ Post-doctoral Fellowship at the Technical University, Munich, Germany (1994-1995). Prof. Cahill became Group Leader of the Protein Technology Group in the Max-Planck-Institute of Molecular Genetics, Berlin (1996-2003). She obtained an Associate Professor position, in the Department of Clinical Pharmacology and Director of Proteomics Core, RCSI, Dublin (2000-2005). Since 2005 – present, she is Full Professor of Translational Science in the School of Medicine, University College Dublin and she has extensive management experience, including successfully obtaining funding from the European Commission (FP4, FP5, FP6, FP7 and Horizon 2020), Science Foundation Ireland, Enterprise Ireland, Health Research Board & successfully writing, project managing, publishing & reporting on all financial & regulatory aspects in academic & private sectors, in the companies she co-founded. She has over 100 peer reviewed publications, with over 5000 citations and a H-index is 31, which is in the top 10% globally for the Biomedicine discipline. Prof. Cahill is internationally recognised for her biomedical research, publications and patent record in life sciences, biotechnology, personalised healthcare, personalised medicine, diagnostics, biomarker discovery and validation, proteomics, biotechnology, high content protein and antibody arrays and their biomedical, diagnostic and clinical applications. Her publications have demonstrated utility and applications in the research, commercial & clinical sectors and include characterisation of antibodies specificity (including therapeutic antibodies), biomarker discovery, diagnostics, assay development, protein-interaction studies, proteomics, large scale/systems biology research, validating biomarker panels in diagnostic clinical trial, personalised medicine and assessing immune related adverse events. She has given over 100 Keynotes Lectures in Ireland, UK, Europe, USA, China, Japan, South Korea, Australia, South America. For example, she is invited to the ‘5th Precision Medicine and Biomarkers Leaders’ Summit’ in Munich in September 2018 & will Chair a Roundtable on Personalised Medicine and Adverse Events to discuss whether lessons can be learned from cancer immunotherapy and immune related adverse events to provide insight into understanding adverse events and personalised medicine and finding adverse event predictive biomarkers

Yohohooooooo....

 

Paragraphs.
 

If you can take the time to read it, you can take the time to re-read it.

[Timbermen]

8 minutes ago, Me_ said:

Yohohooooooo....

 

Paragraphs.
 

If you can take the time to read it, you can take the time to re-read it.

Fixed it, why would you wear a mask if it's only transmitted through droplets?

Edited May 19, 2020 by Timbermen

[Me_]

6 minutes ago, Timbermen said:

Fixed it, why would you wear a mask if it's only transmitted through droplets?

Oh. I see.

 

Because if you wear pants when you piss on yourself, you don’t wet anyone else but yourself.

 

I... don’t know how else... to...

[Timbermen]

17 minutes ago, Me_ said:

Oh. I see.

 

Because if you wear pants when you piss on yourself, you don’t wet anyone else but yourself.

 

I... don’t know how else... to...

Stop speaking moistly.

Spoiler

like a wet fart.

 

Edited May 19, 2020 by Timbermen

[PistolPete13]

11 hours ago, bishopshodan said:

It's really something isn't it?

I'm hearing a lot of about 5G too. I remember a couple years ago learning that countries, like the US,that were way behind in implementing 5G would start slipping in global influence ..and technological supremacy.

Is it a surprise that now conspiracy theories have it that 5G has radiation?etc..etc..

 

Beware the rabbit holes. This false info and manipulation out there is how a con man was able to sneak into the whitehouse. 

I enjoy reading your posts Bishop. 
Thanks for injecting a little sanity.

 

 

[Me_]

2 hours ago, kingofsurrey said:

Hopefully as we get closer to June 1,  BC gov reconsiders and decides to continue online education.  Get a plan for september that allows for elementary kids to be in school full time.  10 kids per class max though.    Look at what Denmark is doing now. ..    Take the time to get it right. 

You know,

 

I am totally for online education. As much as possible. I don’t think the “institution” is fully out of the congregation that is conventional public schooling. 
 

Young kids learn more on mobile units. Mobile units should be supplied if the kid’s family can’t supply it, as well as a place to go for the kids who need such a program as institutionalized education. 
 

This is not to take away from teachers. They can also be better served than current and recent times by a reprogramming of the delivery system that is the tutor/pupil relationship.

 

In this age of extreme freedom in information consumption, our kids at 13 have already been around the world, played every space, talked to everyone and done everything.

 

And we’re there telling them how the world is. It is a necessity to bring responsibility to children.

 

It must be done of course. But some children, give them an iPad and they’re off to the races.

 

Focussing a kid to get to do something is usually easier when they want to do something, and when they see the end to the means.

 

Then they ACE what they need to do almost without effort.

 

It is us, adults, with our personal victim, our judge, and our set of rules, that prevent their creativity from flourishing. 

 

Every child in this country can be served a beautiful future. 
 

Edited May 19, 2020 by Me_

[JoeyJoeJoeJr. Shabadoo]

2 hours ago, Timbermen said:

Facebook, I don't know if she's partisan or just wants to hold people accountable for the deaths they will cause with their policies. I just saw this myself but she's calling out any one that wants to argue with her on National Television, yet you'lll see zero mention of her on CNN. She has more credentials than all the so called journalists that will be attacking her put together.

Prof. Dolores J. Cahill, Professor of Translational Science at UCD School of Medicine, University College Dublin

Prof. Dr Dolores Cahill has over 25 years expertise in high-throughput protein array, antibody array, proteomics technology development,automation and their biomedical applications, including in biomarker discovery, diagnostics and personalised medicine. She is Professor of Translational Science, School of Medicine and at the Conway Institute at the University College Dublin (UCD) (2005-present). With her research group & collaborators, she has achieved key breakthroughs in developing and demonstrating applications of high throughput array technology in biological, diagnostics & medical research. Prof. Cahill pioneered this research at the Max-Planck-Institute of Molecular Genetics in Berlin, Germany (1996-2003) and holds several granted international patents in this vital field. Some of her activities include:

In 1996, she co-founded Protagen AG (https://protagen.com/) in Dortmund, including with Prof. Helmut Meyer, as a spin-out of the Max-Planck-Institute to commercialise her discoveries. Protagen Protein Services (https://protagenproteinservices.com/) a 2014 spin-off company of Protagen delivers expert protein, antibody, proteomics & peptide contract services to the pharmaceutical industry & health care sectors. Both companies have advanced these technologies & applications; Protagen has screened and profiled the autoantibody repertoire of over 20,000 patients (https://protagen.com/data-and-insight...). Protagen AG and Protagen Protein Services have over 200 employees in 2018. Since 2016, Prof. Cahill is a shareholder & Advisory Board member of Atturos Ltd, Prof. Stephen Pennington’s UCD spin-out company nvolved in improved Prostate Cancer diagnosis (http://atturos.com/ and http://atturos.com/company/advisors/).

She received her Honours degree in Molecular Genetics from Trinity College Dublin (1989) and her PhD in Immunology from Dublin City University (1994). While studying in Trinity, she was awarded the Irish American Fellowship Prize (1988) to research at Prof. Pringle’s laboratory in the University of Michigan, Ann Arbor, USA. During her undergraduate & PhD studies, she worked, including as Assistant Manager, in fine-dining Country Clubs in Long Island, New York (4 summers) & in Tenafly, New Jersey (4 summers). On obtaining her PhD, she obtained an EU ‘Human Capital & Mobility’ Post-doctoral Fellowship at the Technical University, Munich, Germany (1994-1995). Prof. Cahill became Group Leader of the Protein Technology Group in the Max-Planck-Institute of Molecular Genetics, Berlin (1996-2003). She obtained an Associate Professor position, in the Department of Clinical Pharmacology and Director of Proteomics Core, RCSI, Dublin (2000-2005). Since 2005 – present, she is Full Professor of Translational Science in the School of Medicine, University College Dublin and she has extensive management experience, including successfully obtaining funding from the European Commission (FP4, FP5, FP6, FP7 and Horizon 2020), Science Foundation Ireland, Enterprise Ireland, Health Research Board & successfully writing, project managing, publishing & reporting on all financial & regulatory aspects in academic & private sectors, in the companies she co-founded.

 She has over 100 peer reviewed publications, with over 5000 citations and a H-index is 31, which is in the top 10% globally for the Biomedicine discipline. Prof. Cahill is internationally recognised for her biomedical research, publications and patent record in life sciences, biotechnology, personalised healthcare, personalised medicine, diagnostics, biomarker discovery and validation, proteomics, biotechnology, high content protein and antibody arrays and their biomedical, diagnostic and clinical applications. Her publications have demonstrated utility and applications in the research, commercial & clinical sectors and include characterisation of antibodies specificity (including therapeutic antibodies), biomarker discovery, diagnostics, assay development, protein-interaction studies, proteomics, large scale/systems biology research, validating biomarker panels in diagnostic clinical trial, personalised medicine and assessing immune related adverse events. She has given over 100 Keynotes Lectures in Ireland, UK, Europe, USA, China, Japan, South Korea, Australia, South America. For example, she is invited to the ‘5th Precision Medicine and Biomarkers Leaders’ Summit’ in Munich in September 2018 & will Chair a Roundtable on Personalised Medicine and Adverse Events to discuss whether lessons can be learned from cancer immunotherapy and immune related adverse events to provide insight into understanding adverse events and personalised medicine and finding adverse event predictive biomarkers

She is also the chairperson of the fringe Irish Freedom Party. A party with ideologies centred on hard euroscepticism, and right wing populism. It also has ties to white nationalism, colour me surprised, lol.

 

The leader of the party apparently tried to peddle Make Ireland Great Again hats so its no surprise that her views align with Trump on the virus. I for one am quite skeptical about Delores based on her hyper partisanship. Also because her name rhymes with a female body part.

 

 

[Me_]

So now Trump claims he’s been taking Hydroxychloroquine and pushes it yet again despite research not being done still.

 

The belief is he’s got it and he’s being administered the drug.

 

We may live in a time where the 73 year old President of the United-States, dies of his own mismanagement of a world pandemic.

 

The irony would kill storytelling overall.

 

Edited May 20, 2020 by Me_

[skolozsy2]

3 hours ago, Timbermen said:

Facebook, I don't know if she's partisan or just wants to hold people accountable for the deaths they will cause with their policies. I just saw this myself but she's calling out any one that wants to argue with her on National Television, yet you'lll see zero mention of her on CNN. She has more credentials than all the so called journalists that will be attacking her put together.

Prof. Dolores J. Cahill, Professor of Translational Science at UCD School of Medicine, University College Dublin

Prof. Dr Dolores Cahill has over 25 years expertise in high-throughput protein array, antibody array, proteomics technology development,automation and their biomedical applications, including in biomarker discovery, diagnostics and personalised medicine. She is Professor of Translational Science, School of Medicine and at the Conway Institute at the University College Dublin (UCD) (2005-present). With her research group & collaborators, she has achieved key breakthroughs in developing and demonstrating applications of high throughput array technology in biological, diagnostics & medical research. Prof. Cahill pioneered this research at the Max-Planck-Institute of Molecular Genetics in Berlin, Germany (1996-2003) and holds several granted international patents in this vital field. Some of her activities include:

In 1996, she co-founded Protagen AG (https://protagen.com/) in Dortmund, including with Prof. Helmut Meyer, as a spin-out of the Max-Planck-Institute to commercialise her discoveries. Protagen Protein Services (https://protagenproteinservices.com/) a 2014 spin-off company of Protagen delivers expert protein, antibody, proteomics & peptide contract services to the pharmaceutical industry & health care sectors. Both companies have advanced these technologies & applications; Protagen has screened and profiled the autoantibody repertoire of over 20,000 patients (https://protagen.com/data-and-insight...). Protagen AG and Protagen Protein Services have over 200 employees in 2018. Since 2016, Prof. Cahill is a shareholder & Advisory Board member of Atturos Ltd, Prof. Stephen Pennington’s UCD spin-out company nvolved in improved Prostate Cancer diagnosis (http://atturos.com/ and http://atturos.com/company/advisors/).

She received her Honours degree in Molecular Genetics from Trinity College Dublin (1989) and her PhD in Immunology from Dublin City University (1994). While studying in Trinity, she was awarded the Irish American Fellowship Prize (1988) to research at Prof. Pringle’s laboratory in the University of Michigan, Ann Arbor, USA. During her undergraduate & PhD studies, she worked, including as Assistant Manager, in fine-dining Country Clubs in Long Island, New York (4 summers) & in Tenafly, New Jersey (4 summers). On obtaining her PhD, she obtained an EU ‘Human Capital & Mobility’ Post-doctoral Fellowship at the Technical University, Munich, Germany (1994-1995). Prof. Cahill became Group Leader of the Protein Technology Group in the Max-Planck-Institute of Molecular Genetics, Berlin (1996-2003). She obtained an Associate Professor position, in the Department of Clinical Pharmacology and Director of Proteomics Core, RCSI, Dublin (2000-2005). Since 2005 – present, she is Full Professor of Translational Science in the School of Medicine, University College Dublin and she has extensive management experience, including successfully obtaining funding from the European Commission (FP4, FP5, FP6, FP7 and Horizon 2020), Science Foundation Ireland, Enterprise Ireland, Health Research Board & successfully writing, project managing, publishing & reporting on all financial & regulatory aspects in academic & private sectors, in the companies she co-founded.

 She has over 100 peer reviewed publications, with over 5000 citations and a H-index is 31, which is in the top 10% globally for the Biomedicine discipline. Prof. Cahill is internationally recognised for her biomedical research, publications and patent record in life sciences, biotechnology, personalised healthcare, personalised medicine, diagnostics, biomarker discovery and validation, proteomics, biotechnology, high content protein and antibody arrays and their biomedical, diagnostic and clinical applications. Her publications have demonstrated utility and applications in the research, commercial & clinical sectors and include characterisation of antibodies specificity (including therapeutic antibodies), biomarker discovery, diagnostics, assay development, protein-interaction studies, proteomics, large scale/systems biology research, validating biomarker panels in diagnostic clinical trial, personalised medicine and assessing immune related adverse events. She has given over 100 Keynotes Lectures in Ireland, UK, Europe, USA, China, Japan, South Korea, Australia, South America. For example, she is invited to the ‘5th Precision Medicine and Biomarkers Leaders’ Summit’ in Munich in September 2018 & will Chair a Roundtable on Personalised Medicine and Adverse Events to discuss whether lessons can be learned from cancer immunotherapy and immune related adverse events to provide insight into understanding adverse events and personalised medicine and finding adverse event predictive biomarkers

That is a terrifying wall of text